Travere Therapeutics, Inc.
TVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001438533
In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.
Superinvestors holding TVTX, Q2 2026
No superinvestor reported holding TVTX in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TVTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
0 superinvestors holding at quarter end
- Sold out
- Viking Global Investors
Q1 2025
1 superinvestor holding at quarter end
- Reduced
- Viking Global Investors (−10.3%)
Q4 2024
1 superinvestor holding at quarter end